Ofir Levi - May 14, 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 04:08 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +15K $0.00 15K May 14, 2021 Common Stock 15K $3.66 Direct F1
transaction GRI Stock Option (Right to Buy) Award $0 +30K $0.00 30K May 14, 2021 Common Stock 30K $3.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021.
F2 The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant.